Low Density Lipoprotein
Native oxidized Human Low Density LipoproteinLow density lipoprotein is provided, purified from human plasma in liquid form. (LDL) oxidative modification is one of the major processes involved in atherosclerosis along with other degenerative disorders. Oxidised LDL is preferentially accumulated by macrophages which become so called "foam cells" within the atheromatous plaque and contributes to the accumulation of cholesterol, typical of atherosclerosis.
- Target Species
- Product Form
- Purified oxidised LDL from human plasma - liquid
- LDL is purified to homogeneity by ultra-centrifugation. Oxidised using 20 µM cupric sulphate in PBS at 37ºC for 24 hours. Oxidation is terminated with excess EDTA. The level of oxidation is measured using TBARS (Thiobarbituric acid reactive substances) determination using a Malondialdehyde (MDA) standard. The level of oxidation is batch specific and available on request.
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.3 mM EDTA
- Approx. Protein Concentrations
- Total protein concentration 2.0 mg/ml
- Store at +4oC. DO NOT FREEZE.
This product should be stored undiluted.
- Shelf Life
- This product is stable for approximately 4 weeks when handled aseptically and stored at 4ºC. Please see label for expiry date.
- For research purposes only
Applications of Low Density Lipoprotein
|Application Name||Verified||Min Dilution||Max Dilution|
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2018 Bio-Rad Antibodies (formerly AbD Serotec)
Product Specific References
References for Low Density Lipoprotein
Yang, K. et al. (2015) Oxidized low-density lipoprotein promotes macrophage lipid accumulation via the toll-like receptor 4-Src pathway.
Circ J. 79 (11): 2509-16.
Wang, X. Q. et al. (2016) C1q/TNF-related protein 1 links macrophage lipid metabolism to inflammation and atherosclerosis
Atherosclerosis. Apr 28 [Epub ahead of print]
Dai, D. et al. (2016) Association of decreased serum sTREM-1 level with the severity of coronary artery disease: Inhibitory effect of sTREM-1 on TNF-α- and oxLDL-induced inflammatory reactions in endothelial cells.
Medicine (Baltimore). 95 (37): e4693.
Zhang, B-C. et al. (2016) Luteolin Attenuates Foam Cell Formation and Apoptosis in Ox-LDL-Stimulated Macrophages by Enhancing Autophagy.
Cell Physiol Biochem. 39 (5): 2065-2076.
Fukushi, S. et al. (2018) Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA.
J Virol Methods. 251: 22-29.
Carbone, M.L. et al. (2017) Leukocyte RhoA exchange factor Arhgef1 mediates vascular inflammation and atherosclerosis.
J Clin Invest. Nov 13 [Epub ahead of print].